(Q38208967)

31 August 2017

title

Hypertension as a risk factor for heart failure (English)

1 reference

31 August 2017

main subject

arterial hypertension

0 references

0 references

0 references

Arun Kannan

1

1 reference

31 August 2017

Rajesh Janardhanan

series ordinal

2

1 reference

31 August 2017

publication date

1 July 2014

1 reference

Current Hypertension Reports

31 August 2017

published in

1 reference

31 August 2017

volume

16

1 reference

31 August 2017

issue

7

1 reference

31 August 2017

page(s)

447

1 reference

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

The progression from hypertension to congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Antihypertensive efficacy of treatment regimens used in Veterans Administration hypertension clinics. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Effect of drug therapy on survival in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

The hypertensive heart. An integrated understanding informed by imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Does load-induced ventricular hypertrophy progress to systolic heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

The human sympathetic nervous system: its relevance in hypertension and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Adverse consequences of high sympathetic nervous activity in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Therapeutic approaches to diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

21 January 2018

Diastolic heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Exacerbation of left ventricular ischemic diastolic dysfunction by pressure-overload hypertrophy. Modification by specific inhibition of cardiac angiotensin converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Left ventricular hypertrophy and clinical outcomes in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study e

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Aldosterone production is activated in failing ventricle in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

Prognosis of left ventricular geometric patterns in the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0447-7

The epidemiology of heart failure: the Framingham Study

21 January 2018

1 reference

12 December 2020

Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program

1 reference

12 December 2020

The heart in hypertension

1 reference

12 December 2020

Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension

1 reference

12 December 2020

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

12 December 2020

Angiotensin II-forming pathways in normal and failing human hearts

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Determinants of abnormal left ventricular filling in early hypertension

1 reference

12 December 2020

Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial

1 reference

12 December 2020

Heart failure with preserved ejection fraction: is this diastolic heart failure?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the Ameri

1 reference

12 December 2020

Cardiomyocyte Stiffness in Diastolic Heart Failure

1 reference

12 December 2020

Treatment of mild hypertension: results of a ten-year intervention trial

1 reference

12 December 2020

An updated concept for left ventricular hypertrophy risk in hypertension

1 reference

12 December 2020

Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial

1 reference

12 December 2020

Capillary growth and geometry during long-term hypertension and myocardial hypertrophy in dogs

1 reference

12 December 2020

Angiotensin receptor blockers for heart failure

1 reference

12 December 2020

Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up

1 reference

12 December 2020

Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study

1 reference

12 December 2020

Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction

1 reference

12 December 2020

Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?

1 reference

12 December 2020

Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy

1 reference

12 December 2020

TOTAL THORACIC AND PARTIAL TO TOTAL LUMBAR SYMPATHECTOMY AND CELIAC GANGLIONECTOMY IN THE TREATMENT OF HYPERTENSION

1 reference

12 December 2020

Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure

1 reference

12 December 2020

Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study

1 reference

12 December 2020

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

12 December 2020

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

12 December 2020

Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation

1 reference

12 December 2020

Prognostic significance of serial changes in left ventricular mass in essential hypertension

1 reference

12 December 2020

Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction

1 reference

12 December 2020

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity

1 reference

12 December 2020

The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview

1 reference

12 December 2020

Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension

1 reference

12 December 2020

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

12 December 2020

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

12 December 2020

Endothelin in human congestive heart failure

1 reference

12 December 2020

10.1007/S11906-014-0447-7

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1009856711

0 references

1 reference